BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sands BE, Kaplan GG. The role of TNFalpha in ulcerative colitis. J Clin Pharmacol. 2007;47:930-941. [PMID: 17567930 DOI: 10.1177/0091270007301623] [Cited by in Crossref: 106] [Cited by in F6Publishing: 118] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Jahnich N, Arkwright PD. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1046306] [Reference Citation Analysis]
2 Sharma S, Bhatia R, Devi K, Rawat A, Singh S, Bhadada SK, Bishnoi M, Sharma SS, Kondepudi KK. A synbiotic combination of Bifidobacterium longum Bif10 and Bifidobacterium breve Bif11, isomaltooligosaccharides and finger millet arabinoxylan prevents dextran sodium sulphate induced ulcerative colitis in mice. Int J Biol Macromol 2023;231:123326. [PMID: 36681226 DOI: 10.1016/j.ijbiomac.2023.123326] [Reference Citation Analysis]
3 Bondoc I, Zamfir M, Mardare M, Văcărașu A, Burlacu A, Ali L, Hudita A, Galateanu B, Ginghină O, Georgiadis G, Mamoulakis C. Ulcerative colitis complicated with Fournier’s gangrene: A case report. Public Health Toxicol 2023;3:1-7. [DOI: 10.18332/pht/159116] [Reference Citation Analysis]
4 Balkrishna A, Singh R, Gohel V, Arora S, Dev R, Bhattacharya K, Varshney A. Enteric-Coated Cologrit Tablet Exhibit Robust Anti-Inflammatory Response in Ulcerative Colitis-like In-Vitro Models by Attuning NFκB-Centric Signaling Axis. Pharmaceuticals (Basel) 2022;16. [PMID: 36678560 DOI: 10.3390/ph16010063] [Reference Citation Analysis]
5 Bagalagel A, Diri R, Noor A, Almasri D, Bakhsh HT, Kutbi HI, Al-gayyar MMH. Curative effects of fucoidan on acetic acid induced ulcerative colitis in rats via modulating aryl hydrocarbon receptor and phosphodiesterase-4. BMC Complement Med Ther 2022;22:196. [DOI: 10.1186/s12906-022-03680-4] [Reference Citation Analysis]
6 Ahmad T, Ishaq M, Karpiniec S, Park A, Stringer D, Singh N, Ratanpaul V, Wolfswinkel K, Fitton H, Caruso V, Eri R. Oral Macrocystis pyrifera Fucoidan Administration Exhibits Anti-Inflammatory and Antioxidant Properties and Improves DSS-Induced Colitis in C57BL/6J Mice. Pharmaceutics 2022;14:2383. [DOI: 10.3390/pharmaceutics14112383] [Reference Citation Analysis]
7 Swedik SM, Madola A, Cruz MA, Llorens-Bonilla BJ, Levine AD. Th17-Derived Cytokines Synergistically Enhance IL-17C Production by the Colonic Epithelium. J Immunol 2022;209:1768-77. [PMID: 36130829 DOI: 10.4049/jimmunol.2200125] [Reference Citation Analysis]
8 Yin J, Ju Y, Qian H, Wang J, Miao X, Zhu Y, Zhou L, Ye L. Nanoplastics and Microplastics May Be Damaging Our Livers. Toxics 2022;10:586. [PMID: 36287866 DOI: 10.3390/toxics10100586] [Reference Citation Analysis]
9 Kan H, Zhang D, Chen W, Wang S, He Z, Pang S, Qu S, Wang Y. Identification of anti-inflammatory components in Panax ginseng of Sijunzi Decoction based on spectrum-effect relationship. Chinese Herbal Medicines 2022. [DOI: 10.1016/j.chmed.2022.04.003] [Reference Citation Analysis]
10 Gordon BL, Galati JS, Yang S, Longman RS, Lukin D, Scherl EJ, Battat R. Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease. World J Gastroenterol 2022; 28(33): 4834-4845 [DOI: 10.3748/wjg.v28.i33.4834] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hao W, Chen Z, Wang L, Yuan Q, Gao C, Ma M, Liu C, Wang Y, Wang S. Classical prescription Huanglian Decoction relieves ulcerative colitis via maintaining intestinal barrier integrity and modulating gut microbiota. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154468] [Reference Citation Analysis]
12 Lee J, Chung K, Shin J, Jung S, Lee S, Lee M, Hong H, Rhee YK, Lee K. Anti-Colitic Effect of an Exopolysaccharide Fraction from Pediococcus pentosaceus KFT-18 on Dextran Sulfate Sodium-Induced Colitis through Suppression of Inflammatory Mediators. Polymers 2022;14:3594. [DOI: 10.3390/polym14173594] [Reference Citation Analysis]
13 Hao W, Chen Z, Yuan Q, Ma M, Gao C, Zhou Y, Zhou H, Wu X, Wu D, Farag MA, Wang S, Wang Y. Ginger polysaccharides relieve ulcerative colitis via maintaining intestinal barrier integrity and gut microbiota modulation. Int J Biol Macromol 2022;219:730-9. [PMID: 35963344 DOI: 10.1016/j.ijbiomac.2022.08.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dhall A, Patiyal S, Choudhury S, Jain S, Narang K, Raghava GPS. Prediction, scanning and designing of TNF-α inducing epitopes for human and mouse.. [DOI: 10.1101/2022.08.02.502430] [Reference Citation Analysis]
15 Dibekoğlu C, Erbaş O. Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model. Acta Cir Bras 2022;37:e370503. [PMID: 35894303 DOI: 10.1590/acb370503] [Reference Citation Analysis]
16 Lazcano-silveira R, Jia X, Liu K, Liu H, Li X, Hui M. Carbon 60 Dissolved in Grapeseed Oil Inhibits Dextran Sodium Sulfate-Induced Experimental Colitis. JIR 2022;Volume 15:4185-98. [DOI: 10.2147/jir.s366886] [Reference Citation Analysis]
17 Siel D, Beltrán CJ, Martínez E, Pino M, Vargas N, Salinas A, Pérez O, Pereira I, Ramírez-Toloza G. Elucidating the Role of Innate and Adaptive Immune Responses in the Pathogenesis of Canine Chronic Inflammatory Enteropathy-A Search for Potential Biomarkers. Animals (Basel) 2022;12:1645. [PMID: 35804545 DOI: 10.3390/ani12131645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 da Silva EM, Yariwake VY, Alves RW, de Araujo DR, Andrade-Oliveira V. Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases. Peptides 2022;:170834. [PMID: 35753504 DOI: 10.1016/j.peptides.2022.170834] [Reference Citation Analysis]
19 Islam SMS, Ryu HM, Sohn S. Tetragenococcus halophilus Alleviates Intestinal Inflammation in Mice by Altering Gut Microbiota and Regulating Dendritic Cell Activation via CD83. Cells 2022;11:1903. [PMID: 35741032 DOI: 10.3390/cells11121903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
20 Kumar Sinha P. THE POSSIBLE CURE OF ULCERATIVE COLITIS BASED ON THE HYPOTHESIS THAT SOME CANCERS ARE RICH SOURCE OF NON- APOPTOTIC AND FUNCTIONAL TREG CELLS. PIJR 2022. [DOI: 10.36106/paripex/7601149] [Reference Citation Analysis]
21 Vukelic I, Buljevic S, Baticic L, Barisic K, Franovic B, Detel D. CD26 Deficiency Controls Macrophage Polarization Markers and Signal Transducers during Colitis Development and Resolution. IJMS 2022;23:5506. [DOI: 10.3390/ijms23105506] [Reference Citation Analysis]
22 Kim ES, Kim SK, Park DI, Kim HJ, Lee YJ, Koo JS, Kim ES, Yoon H, Lee JH, Kim JW, Shin SJ, Kim HW, Kim HS, Park YS, Kim YS, Kim TO, Lee J, Choi CH, Han DS, Chun J, Kim HS; IBD Research Group in the Korean Association for the Study of Intestinal Diseases. Comparison of the Pharmacokinetics of CT-P13 Between Crohn's Disease and Ulcerative Colitis. J Clin Gastroenterol 2022. [PMID: 35470308 DOI: 10.1097/MCG.0000000000001715] [Reference Citation Analysis]
23 Zhu T, Hu B, Ye C, Hu H, Yin M, Zhang Z, Li S, Liu Y, Liu H. Bletilla striata Oligosaccharides Improve Ulcerative Colitis by Regulating Gut Microbiota and Intestinal Metabolites in Dextran Sulfate Sodium-Induced Mice. Front Pharmacol 2022;13:867525. [DOI: 10.3389/fphar.2022.867525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kozhakhmetov S, Babenko D, Kozhakhmetova S, Tuyakova A, Nurgaziyev M, Nurgozhina A, Muhanbetganov N, Chulenbayeva L, Sergazy S, Gulyayev A, Aljofan M, Kushugulova A, Arunachalam K. Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare’s Milk in the Treatment of Dysbiosis. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/3851478] [Reference Citation Analysis]
25 Xiao Y, Tan C, Nie X, Li B, You M, Lan Y, Tang L. Rise in Postprandial GLP-1 Levels After Roux-en-Y Gastric Bypass: Involvement of the Vagus Nerve-Spleen Anti-inflammatory Axis in Type 2 Diabetic Rats. Obes Surg 2022. [PMID: 35044600 DOI: 10.1007/s11695-021-05877-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Jeon Y, Kim S. Ameliorative Effect of Pu-erh Tea on DSS-induced Colitis through Regulation of NF-κB Activation in Mice. Biomed Sci Letters 2021;27:248-254. [DOI: 10.15616/bsl.2021.27.4.248] [Reference Citation Analysis]
27 Manzini R, Schwarzfischer M, Atrott K, Laimbacher A, Lang S, Wawrzyniak M, Rickenbacher A, Turina M, Hruz P, Lissner D, Siegmund B, Rogler G, Scharl M, Spalinger MR. Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis. Inflamm Bowel Dis 2021;27:1986-98. [PMID: 33847343 DOI: 10.1093/ibd/izab063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Rashidian A, Akbarzadeh D, Asgarpanah J, Dehpour A. Bunium persicum essential oil reduced acetic acid-induced rat colitis through suppression of NF-κB pathway. Avicenna J Phytomed 2021;11:505-14. [PMID: 34745922 DOI: 10.22038/AJP.2021.18037] [Reference Citation Analysis]
29 Koushki K, Keshavarz Shahbaz S, Keshavarz M, Bezsonov EE, Sathyapalan T, Sahebkar A. Gold Nanoparticles: Multifaceted Roles in the Management of Autoimmune Disorders. Biomolecules 2021;11:1289. [PMID: 34572503 DOI: 10.3390/biom11091289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
30 Wang D, Shao S, Zhang Y, Zhao D, Wang M. Insight Into Polysaccharides From Panax ginseng C. A. Meyer in Improving Intestinal Inflammation: Modulating Intestinal Microbiota and Autophagy. Front Immunol 2021;12:683911. [PMID: 34354704 DOI: 10.3389/fimmu.2021.683911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Ren Y, Jiang W, Luo C, Zhang X, Huang M. Atractylenolide III Ameliorates TNBS-Induced Intestinal Inflammation in Mice by Reducing Oxidative Stress and Regulating Intestinal Flora. Chem Biodivers 2021;18:e2001001. [PMID: 34156157 DOI: 10.1002/cbdv.202001001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Yeom J, Ma S, Kim JK, Lim YH. Oxyresveratrol Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats by Suppressing Inflammation. Molecules 2021;26:2630. [PMID: 33946346 DOI: 10.3390/molecules26092630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Onozato D, Ogawa I, Kida Y, Mizuno S, Hashita T, Iwao T, Matsunaga T. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells. J Pharm Sci 2021;110:2637-50. [PMID: 33794275 DOI: 10.1016/j.xphs.2021.03.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Hagan M, Hayee BH, Rodriguez-Mateos A. (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review. Molecules 2021;26:1843. [PMID: 33805938 DOI: 10.3390/molecules26071843] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
35 Wu F, Li H, Zhang H, Liao Y, Ren H, Wu J, Zheng D. Phosphorylated‑myosin light chain mediates the destruction of small intestinal epithelial tight junctions in mice with acute liver failure. Mol Med Rep 2021;23:392. [PMID: 33760163 DOI: 10.3892/mmr.2021.12031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR, Yang SH. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci 2021;22:2719. [PMID: 33800290 DOI: 10.3390/ijms22052719] [Cited by in Crossref: 86] [Cited by in F6Publishing: 106] [Article Influence: 43.0] [Reference Citation Analysis]
37 Liu SS, Xu YS, Hilola A, Zhou N, He M, Zhang CG, Liu H. Study on the effect of the treatment of Periplaneta americana L. extract Ento-B by Dinitrochlorobenzene combined with acetic acid induced UC in rats. Acta Cir Bras 2021;36:e360102. [PMID: 33605307 DOI: 10.1590/ACB360102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Zheng H, Wang J, Wei X, Chang L, Liu S. Proinflammatory properties and lipid disturbance of polystyrene microplastics in the livers of mice with acute colitis. Science of The Total Environment 2021;750:143085. [DOI: 10.1016/j.scitotenv.2020.143085] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 21.5] [Reference Citation Analysis]
39 Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:643-54. [PMID: 33121686 DOI: 10.1016/j.gtc.2020.07.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 21.3] [Reference Citation Analysis]
40 Kim NH, Lee SM, Kim YN, Jeon YJ, Heo JD, Jeong EJ, Rho JR. Standardized Fraction of Turbinaria ornata Alleviates Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice via Upregulation of FOXP3+ Regulatory T Cells. Biomolecules 2020;10:E1463. [PMID: 33092149 DOI: 10.3390/biom10101463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Chakraborty D, Wang J. Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. Life Sci 2020;262:118507. [PMID: 33017572 DOI: 10.1016/j.lfs.2020.118507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
42 Shodeinde AB, Murphy AC, Oldenkamp HF, Potdar AS, Ludolph CM, Peppas NA. Recent Advances in Smart Biomaterials for the Detection and Treatment of Autoimmune Diseases. Adv Funct Mater 2020;30:1909556. [PMID: 33071713 DOI: 10.1002/adfm.201909556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
43 Arya VS, Kanthlal SK, Linda G. The role of dietary polyphenols in inflammatory bowel disease: A possible clue on the molecular mechanisms involved in the prevention of immune and inflammatory reactions. J Food Biochem 2020;44:e13369. [PMID: 32885438 DOI: 10.1111/jfbc.13369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
44 Formiga RO, Alves Júnior EB, Vasconcelos RC, Guerra GCB, Antunes de Araújo A, Carvalho TG, Garcia VB, de Araújo Junior RF, Gadelha FAAF, Vieira GC, Sobral MV, Barbosa Filho JM, Spiller F, Batista LM. p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and Immunomodulation. Int J Mol Sci 2020;21:E5870. [PMID: 32824269 DOI: 10.3390/ijms21165870] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
45 Li J, Liu L, Zhao Q, Chen M. Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice. Dig Dis Sci 2020;65:1971-9. [PMID: 31808003 DOI: 10.1007/s10620-019-05969-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
46 Pavia CS, Plummer MM. Clinical implications of nicotine as an antimicrobial agent and immune modulator. Biomed Pharmacother 2020;129:110404. [PMID: 32603888 DOI: 10.1016/j.biopha.2020.110404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
47 Goudarzi R, Partoazar A, Mumtaz F, Yousefi-Manesh H, Abdollahi A, Dehpour A, Rashidian A. Arthrocen, an avocado-soy unsaponifiable agent, improves acetic acid-induced colitis in rat by inhibition of NF-kB signaling pathway. J Food Biochem 2020;44:e13244. [PMID: 32441355 DOI: 10.1111/jfbc.13244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
48 Kaur A, Goggolidou P. Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies. J Inflamm (Lond) 2020;17:15. [PMID: 32336953 DOI: 10.1186/s12950-020-00246-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
49 Berends SE, Strik AS, Löwenberg M, D'Haens GR, Mathôt RAA. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. Clin Pharmacokinet 2019;58:15-37. [PMID: 29752633 DOI: 10.1007/s40262-018-0676-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 15.7] [Reference Citation Analysis]
50 El Naggar EE, Mohamed EA, Borg TM, El-Sheakh AR, Hamed MF. Colon Targeting of Naringin for Enhanced Cytoprotection Against Indomethacin-Induced Colitis in Rabbits. Drug Des Devel Ther 2020;14:677-96. [PMID: 32109993 DOI: 10.2147/DDDT.S218357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
51 Güvenç M, Cellat M, Özkan H, Tekeli İO, Uyar A, Gökçek İ, İşler CT, Yakan A. Protective Effects of Tyrosol Against DSS-Induced Ulcerative Colitis in Rats. Inflammation 2019;42:1680-91. [PMID: 31115770 DOI: 10.1007/s10753-019-01028-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
52 Ranasinghe R, Fernando R, Perera AP, Shastri M, Basheer W, Scowen P, Pinfold T, Eri R. Ccr6 Deficiency Attenuates Spontaneous Chronic Colitis in Winnie. GastrointestDisord 2020;2:27-47. [DOI: 10.3390/gidisord2010004] [Reference Citation Analysis]
53 El-hady SM, Aboughaly MH, El-ashmoony MM, Helmy HS, El-gazayerly ON. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. International Journal of Pharmaceutics 2020;576:118982. [DOI: 10.1016/j.ijpharm.2019.118982] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
54 Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res 2020;34:1123-33. [PMID: 31802559 DOI: 10.1002/ptr.6581] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
55 Wang C, Li W, Wang H, Ma Y, Zhao X, Zhang X, Yang H, Qian J, Li J. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota. BMC Microbiol 2019;19:246. [PMID: 31694526 DOI: 10.1186/s12866-019-1610-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 15.8] [Reference Citation Analysis]
56 De Guerra VC, Hashmi H, Kramer B, Balluz R, Son MB, Stein D, Lieberman A, Zahra M, Abdul-Aziz R. A Case Report of Takayasu's Arteritis and Ulcerative Colitis in a Pediatric Patient with Chronic Recurrent Multifocal Osteomyelitis Successfully Treated with Infliximab: Diagnostic Clues in Disease Associations and Immune Dysregulation. Case Rep Rheumatol 2019;2019:8157969. [PMID: 31285932 DOI: 10.1155/2019/8157969] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Chen YX, Zhang XQ, Yu CG, Huang SL, Xie Y, Dou XT, Liu WJ, Zou XP. Artesunate exerts protective effects against ulcerative colitis via suppressing Toll‑like receptor 4 and its downstream nuclear factor‑κB signaling pathways. Mol Med Rep 2019;20:1321-32. [PMID: 31173225 DOI: 10.3892/mmr.2019.10345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
58 Stavsky J, Maitra R. The Synergistic Role of Diet and Exercise in the Prevention, Pathogenesis, and Management of Ulcerative Colitis: An Underlying Metabolic Mechanism. Nutr Metab Insights 2019;12:1178638819834526. [PMID: 30911221 DOI: 10.1177/1178638819834526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Ait-oudhia S, Lien YTK, Basu S, Lesko L, Schmidt S. Application of Pharmacometrics and Systems Pharmacology to Current and Emerging Biologics in Inflammatory Bowel Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases 2019. [DOI: 10.1002/9781119289234.ch10] [Reference Citation Analysis]
60 Schreurs RRCE, Baumdick ME, Sagebiel AF, Kaufmann M, Mokry M, Klarenbeek PL, Schaltenberg N, Steinert FL, van Rijn JM, Drewniak A, The SML, Bakx R, Derikx JPM, de Vries N, Corpeleijn WE, Pals ST, Gagliani N, Friese MA, Middendorp S, Nieuwenhuis EES, Reinshagen K, Geijtenbeek TBH, van Goudoever JB, Bunders MJ. Human Fetal TNF-α-Cytokine-Producing CD4+ Effector Memory T Cells Promote Intestinal Development and Mediate Inflammation Early in Life. Immunity 2019;50:462-476.e8. [PMID: 30770246 DOI: 10.1016/j.immuni.2018.12.010] [Cited by in Crossref: 98] [Cited by in F6Publishing: 104] [Article Influence: 24.5] [Reference Citation Analysis]
61 Renna S, Mocciaro F, Ventimiglia M, Orlando R, Macaluso FS, Cappello M, Fries W, Mendolaro M, Privitera AC, Ferracane C, Pisana V, Magnano A, Pluchino D, Inserra G, Scarpulla G, Garufi S, Carroccio A, Siringo S, Di Mitri R, Cottone M, Orlando A. A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. Dig Liver Dis 2018;50:1292-8. [PMID: 30007516 DOI: 10.1016/j.dld.2018.06.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
62 Smrekar N, Drobne D, Smid LM, Ferkolj I, Stabuc B, Ihan A, Kopitar AN. Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease. Radiol Oncol 2018;52:443-52. [PMID: 30511938 DOI: 10.2478/raon-2018-0045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
63 Kim SY, Park MJ, Kwon JE, Choi SY, Seo HB, Jung KA, Choi JW, Baek JA, Lee HH, Lee BI, Park SH, Cho ML. Ro60 Inhibits Colonic Inflammation and Fibrosis in a Mouse Model of Dextran Sulfate Sodium-Induced Colitis. Immunol Lett 2018;201:45-51. [PMID: 30395870 DOI: 10.1016/j.imlet.2018.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
64 Vukelić I, Detel D, Pučar LB, Potočnjak I, Buljević S, Domitrović R. Chlorogenic acid ameliorates experimental colitis in mice by suppressing signaling pathways involved in inflammatory response and apoptosis. Food and Chemical Toxicology 2018;121:140-50. [DOI: 10.1016/j.fct.2018.08.061] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
65 Nunes NS, Kim S, Sundby M, Chandran P, Burks SR, Paz AH, Frank JA. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World J Gastroenterol 2018; 24(38): 4341-4355 [PMID: 30344419 DOI: 10.3748/wjg.v24.i38.4341] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
66 Wang X, Wang H, Pierre JF, Wang S, Huang H, Zhang J, Liang S, Zeng Q, Zhang C, Huang M, Ruan C, Lin J, Li H. Marine microalgae bioengineered Schizochytrium sp. meal hydrolysates inhibits acute inflammation. Sci Rep 2018;8:9848. [PMID: 29959357 DOI: 10.1038/s41598-018-28064-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
67 Girgiss Nicola W, Wassef Girgiss M, Mohamed Ezz El-arab A, Ahmed A, Refaat Youness E. Role of Inulin in the Protection and Management of Metabolic Inflammation in Humans. Biomed Pharmacol J 2018;11:1083-1090. [DOI: 10.13005/bpj/1469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
68 Aloi M, Bramuzzo M, Arrigo S, Romano C, D'Arcangelo G, Lacorte D, Gatti S, Illiceto MT, Zucconi F, Dilillo D, Zuin G, Knafelz D, Ravelli A, Cucchiara S, Alvisi P; SIGENP IBD Working Group. Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry. J Pediatr Gastroenterol Nutr 2018;66:920-5. [PMID: 29315163 DOI: 10.1097/MPG.0000000000001883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
69 Salisbury TD, Laghari MH, Yoshida EM, Webber DL. Rectal polypoid Inflammatory Myofibroblastic Tumor in 39-year-old liver transplant recipient with de-novo ulcerative colitis: A case report and literature review. Human Pathology: Case Reports 2018;12:77-82. [DOI: 10.1016/j.ehpc.2018.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Meštrović A, Žaja I, Ardalić Ž, Vrebalov-Cindro P, Šustić I, Puljiz M, Bratanić A, Bonacin D. A Patient with Ulcerative Colitis Complicated by Systemic Vein Thrombosis. Case Rep Gastroenterol 2018;12:322-6. [PMID: 30022923 DOI: 10.1159/000488191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Ren K, Yong C, Yuan H, Cao B, Zhao K, Wang J. TNF-α inhibits SCF, ghrelin, and substance P expressions through the NF-κB pathway activation in interstitial cells of Cajal. Braz J Med Biol Res 2018;51:e7065. [PMID: 29694505 DOI: 10.1590/1414-431x20187065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
72 Zhong X, Lee HN, Surh YJ. RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells. Biochem Biophys Res Commun 2018;496:316-23. [PMID: 29305860 DOI: 10.1016/j.bbrc.2017.12.171] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
73 Rezayat SM, Dehpour AR, Motamed SM, Yazdanparast M, Chamanara M, Sahebgharani M, Rashidian A. Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway. Inflammopharmacology 2018;26:851-9. [PMID: 29067571 DOI: 10.1007/s10787-017-0409-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
74 Ahmad H, Verma S, Kumar VL. Effect of roxithromycin on mucosal damage, oxidative stress and pro-inflammatory markers in experimental model of colitis. Inflamm Res 2018;67:147-55. [PMID: 28988395 DOI: 10.1007/s00011-017-1103-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
75 Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev. 2017;30:191-231. [PMID: 27856521 DOI: 10.1128/cmr.00049-16] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
76 Suluvoy JK, Sakthivel KM, Guruvayoorappan C, Berlin Grace VM. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines. Biomed Pharmacother. 2017;91:1113-1121. [PMID: 28531922 DOI: 10.1016/j.biopha.2017.05.057] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
77 Hibi T, Imai Y, Senoo A, Ohta K, Ukyo Y. Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study). J Gastroenterol 2017;52:1101-11. [PMID: 28324167 DOI: 10.1007/s00535-017-1326-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
78 Suzuki Y, Motoya S, Hanai H, Hibi T, Nakamura S, Lazar A, Robinson AM, Skup M, Mostafa NM, Huang B, Thakkar R, Watanabe M. Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis. J Gastroenterol 2017;52:1031-40. [PMID: 28321512 DOI: 10.1007/s00535-017-1325-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
79 Strik AS, Berends SE, Mathôt RA, D'Haens GR, Löwenberg M. Golimumab for moderate to severe ulcerative colitis. Expert Rev Gastroenterol Hepatol 2017;11:401-6. [PMID: 28276288 DOI: 10.1080/17474124.2017.1303376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
80 Oh YJ, Kim D, Oh S, Jang EJ, Won HY, Jeong H, Jeong MG, Choo HP, Hwang ES. Novel benzoxazole derivatives DCPAB and HPAB attenuate Th1 cell-mediated inflammation through T-bet suppression. Sci Rep 2017;7:42144. [PMID: 28169371 DOI: 10.1038/srep42144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
81 Chen X, Hou J, Yuan Y, Huang C, Liu T, Mo C, Li H, Chen B, Xu Q, Hou Z, He W, Liu F. Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis. BioDrugs 2016;30:207-17. [PMID: 27120055 DOI: 10.1007/s40259-016-0173-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
82 Reinisch W. Biologic Therapy of Ulcerative Colitis: Adalimumab. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_43] [Reference Citation Analysis]
83 Lam M, Bressler B. Biologic Therapy in Moderate-to-Severe Ulcerative Colitis: Infliximab. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_42] [Reference Citation Analysis]
84 Yang Y, He J, Suo Y, Lv L, Wang J, Huo C, Zheng Z, Wang Z, Li J, Sun W, Zhang Y. Anti-inflammatory effect of taurocholate on TNBS-induced ulcerative colitis in mice. Biomedicine & Pharmacotherapy 2016;81:424-30. [DOI: 10.1016/j.biopha.2016.04.037] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
85 Morin C, Blier PU, Fortin S. MAG-EPA reduces severity of DSS-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 2016;310:G808-21. [PMID: 27012773 DOI: 10.1152/ajpgi.00136.2015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
86 Dinh CH, Yu Y, Szabo A, Zhang Q, Zhang P, Huang XF. Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice. J Histochem Cytochem. 2016;64:237-255. [PMID: 26920068 DOI: 10.1369/0022155416631803] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
87 Balaha M, Kandeel S, Elwan W. Garlic oil inhibits dextran sodium sulfate-induced ulcerative colitis in rats. Life Sci 2016;146:40-51. [PMID: 26780265 DOI: 10.1016/j.lfs.2016.01.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
88 Abutorabi R, Baradaran A, Sadat Mostafavi F, Zarrin Y, Mardanian F. Evaluation of Tumor Necrosis Factor Alpha Polymorphism Frequencies in Endometriosis. Int J Fertil Steril 2015;9:329-37. [PMID: 26644856 DOI: 10.22074/ijfs.2015.4548] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
89 Lean QY, Eri RD, Randall-Demllo S, Sohal SS, Stewart N, Peterson GM, Gueven N, Patel RP. Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses. PLoS One 2015;10:e0134259. [PMID: 26218284 DOI: 10.1371/journal.pone.0134259] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
90 Kim SJ, Goldstein J, Dorso K, Merad M, Mayer L, Crawford JM, Gregersen PK, Diamond B. Expression of Blimp-1 in dendritic cells modulates the innate inflammatory response in dextran sodium sulfate-induced colitis. Mol Med 2015;20:707-19. [PMID: 25826676 DOI: 10.2119/molmed.2014.00231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
91 De Toni L, Di Nisio A, Magagna S, Michielan A, Martinato M, Sturniolo GC, D'Incà R, Foresta C, Garolla A. Altered chemokine signalling in endothelial progenitor cells from acute ulcerative colitis patients. Gastroenterol Res Pract 2015;2015:843980. [PMID: 25737719 DOI: 10.1155/2015/843980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 Ding H, Gan HZ, Fan WJ, Cao LY, Xu JM, Mei Q. Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis. Dig Dis Sci 2015;60:375-81. [PMID: 25293822 DOI: 10.1007/s10620-014-3379-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
93 Colombel JF, Sandborn WJ, Ghosh S, Wolf DC, Panaccione R, Feagan B, Reinisch W, Robinson AM, Lazar A, Kron M, Huang B, Skup M, Thakkar RB. Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3. Am J Gastroenterol 2014;109:1771-80. [PMID: 25155227 DOI: 10.1038/ajg.2014.242] [Cited by in Crossref: 103] [Cited by in F6Publishing: 100] [Article Influence: 11.4] [Reference Citation Analysis]
94 Arora Z, Shen B. Biological therapy for ulcerative colitis. Gastroenterol Rep (Oxf) 2015;3:103-9. [PMID: 25344680 DOI: 10.1093/gastro/gou070] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
95 Rana SV, Sharma S, Kaur J, Prasad KK, Sinha SK, Kochhar R, Malik A, Morya RK. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients. J Crohns Colitis 2014;8:859-65. [PMID: 24456736 DOI: 10.1016/j.crohns.2014.01.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
96 Guo L, Li CP. Mechanisms underlying therapeutic effects of curcumin on ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(20): 2863-2869 [DOI: 10.11569/wcjd.v22.i20.2863] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology & Therapeutics 2014;141:272-82. [DOI: 10.1016/j.pharmthera.2013.10.010] [Cited by in Crossref: 251] [Cited by in F6Publishing: 264] [Article Influence: 27.9] [Reference Citation Analysis]
98 Ali T, Choe J, Awab A, Wagener TL, Orr WC. Sleep, immunity and inflammation in gastrointestinal disorders. World J Gastroenterol 2013; 19(48): 9231-9239 [PMID: 24409051 DOI: 10.3748/wjg.v19.i48.9231] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
99 Suzuki Y, Motoya S, Hanai H, Matsumoto T, Hibi T, Robinson AM, Mostafa NM, Chao J, Arora V, Camez A. Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis. J Gastroenterol. 2014;49:283-294. [PMID: 24363029 DOI: 10.1007/s00535-013-0922-y] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 10.3] [Reference Citation Analysis]
100 Burness CB, Keating GM. Adalimumab: a review of its use in the treatment of patients with ulcerative colitis. BioDrugs 2013;27:247-62. [PMID: 23580096 DOI: 10.1007/s40259-013-0033-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
101 Cromer WE, Ganta CV, Patel M, Traylor J, Kevil CG, Alexander JS, Mathis JM. VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy. J Transl Med. 2013;11:207. [PMID: 24020796 DOI: 10.1186/1479-5876-11-207] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
102 Tanisawa K, Mikami E, Fuku N, Honda Y, Honda S, Ohsawa I, Ito M, Endo S, Ihara K, Ohno K, Kishimoto Y, Ishigami A, Maruyama N, Sawabe M, Iseki H, Okazaki Y, Hasegawa-Ishii S, Takei S, Shimada A, Hosokawa M, Mori M, Higuchi K, Takeda T, Higuchi M, Tanaka M. Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes. BMC Genomics 2013;14:248. [PMID: 23586671 DOI: 10.1186/1471-2164-14-248] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
103 Papaconstantinou I, Stamatis K, Tzathas C, Vassiliou I, Giokas G, Gazouli M. The role of variations within microRNA in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2013;25:399-403. [PMID: 23466513 DOI: 10.1097/MEG.0b013e32835c34ea] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
104 Kannan N, Guruvayoorappan C. Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators. Int Immunopharmacol. 2013;16:57-66. [PMID: 23538025 DOI: 10.1016/j.intimp.2013.03.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
105 Chen C, Yu CG. Effect of vascular endothelial cells on the pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2013; 21(7): 585-590 [DOI: 10.11569/wcjd.v21.i7.585] [Reference Citation Analysis]
106 Tang X, Yang Y, Yuan H, You J, Burkatovskaya M, Amar S. Novel transcriptional regulation of VEGF in inflammatory processes. J Cell Mol Med 2013;17:386-97. [PMID: 23414097 DOI: 10.1111/jcmm.12020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
107 Speca S, Giusti I, Rieder F, Latella G. Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol 2012; 18(28): 3635-3661 [PMID: 22851857 DOI: 10.3748/wjg.v18.i28.3635] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 177] [Article Influence: 15.7] [Reference Citation Analysis]
108 Mouzaoui S, Rahim I, Djerdjouri B. Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice. Int Immunopharmacol. 2012;12:302-311. [PMID: 22036766 DOI: 10.1016/j.intimp.2011.10.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
109 Lu P, Burger-van Paassen N, van der Sluis M, Witte-Bouma J, Kerckaert JP, van Goudoever JB, Van Seuningen I, Renes IB. Colonic gene expression patterns of mucin Muc2 knockout mice reveal various phases in colitis development. Inflamm Bowel Dis 2011;17:2047-57. [PMID: 21910166 DOI: 10.1002/ibd.21592] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
110 Juuti-Uusitalo K, Klunder LJ, Sjollema KA, Mackovicova K, Ohgaki R, Hoekstra D, Dekker J, van Ijzendoorn SC. Differential effects of TNF (TNFSF2) and IFN-γ on intestinal epithelial cell morphogenesis and barrier function in three-dimensional culture. PLoS One 2011;6:e22967. [PMID: 21853060 DOI: 10.1371/journal.pone.0022967] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
111 Ganjare AB, Nirmal SA, Patil AN. Use of apigenin from Cordia dichotoma in the treatment of colitis. Fitoterapia. 2011;82:1052-1056. [PMID: 21745550 DOI: 10.1016/j.fitote.2011.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
112 Zaware BB, Nirmal SA, Baheti DG, Patil AN, Mandal SC. Potential of Vitex negundo roots in the treatment of ulcerative colitis in mice. Pharm Biol. 2011;49:874-878. [PMID: 21591873 DOI: 10.3109/13880209.2010.551778] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
113 Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011; 17(5): 578-593 [PMID: 21350707 DOI: 10.3748/wjg.v17.i5.578] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 112] [Article Influence: 8.7] [Reference Citation Analysis]
114 Damin DC, Santos FS, Heck R, Rosito MA, Meurer L, Kliemann LM, Roesler R, Schwartsmann G. Effects of the gastrin-releasing peptide antagonist RC-3095 in a rat model of ulcerative colitis. Dig Dis Sci 2010;55:2203-10. [PMID: 19894117 DOI: 10.1007/s10620-009-1032-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
115 Mosnier J, Jarry A, Camdessanché J, Antoine J, Laboisse CL. In situ evidence of involvement of Schwann cells in ulcerative colitis: autocrine and paracrine signaling by A disintegrin and metalloprotease-17–mediated tumor necrosis factor α production. Human Pathology 2009;40:1159-67. [DOI: 10.1016/j.humpath.2008.11.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
116 Ng SC, Kamm MA. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009;15:935-50. [PMID: 18985710 DOI: 10.1002/ibd.20797] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
117 Lakshmi KV, Shetty P, Vottam K, Govindhan S, Ahmad SN, Hasan Q. Tumor necrosis factor alpha -C850T polymorphism is significantly associated with endometriosis in Asian Indian women. Fertil Steril 2010;94:453-6. [PMID: 19394608 DOI: 10.1016/j.fertnstert.2009.03.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
118 Arafa HM, Hemeida RA, El-Bahrawy AI, Hamada FM. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food Chem Toxicol. 2009;47:1311-1317. [PMID: 19285535 DOI: 10.1016/j.fct.2009.03.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 89] [Article Influence: 6.1] [Reference Citation Analysis]
119 Terry PD, Villinger F, Bubenik GA, Sitaraman SV. Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research. Inflamm Bowel Dis 2009;15:134-40. [PMID: 18626968 DOI: 10.1002/ibd.20527] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
120 Abdin AA, Saeid EM. An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without "olsalazine". J Crohns Colitis 2008;2:296-303. [PMID: 21172227 DOI: 10.1016/j.crohns.2008.04.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
121 Pena-Rossi C, Schreiber S, Golubovic G, Mertz-Nielsen A, Panes J, Rachmilewitz D, Shieh MJ, Simanenkov VI, Stanton D, Graffner H. Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis. Aliment Pharmacol Ther 2008;28:758-67. [PMID: 19145731 DOI: 10.1111/j.1365-2036.2008.03778.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]